09:17 AM EST, 12/23/2024 (MT Newswires) -- VYNE Therapeutics ( VYNE ) shares were edging higher Monday morning after the biopharmaceutical company reported positive phase 1a results for its novel BD2-selective BET inhibitor VYN202. The company said the results support the inhibitor's potential as a new oral treatment for various immune-mediated disorders. VYN202 showed a favorable safety and tolerability profile...

09:16 AM EST, 12/23/2024 (MT Newswires) -- Wave Life Sciences ( WVE ) said Monday it has filed its first clinical trial application for WVE-007 to treat obesity. The company said it expects approval of the clinical trial application and the start of the first-in-human trial of WVE-007 in Q1 2025. WVE-007 is a new approach to treat obesity that...

GDANSK (Reuters) - A subsidiary of Polish e-commerce platform Allegro on Monday filed a lawsuit against Google-owner Alphabet, Google Ireland, and Google LLC, seeking 2.33 billion zlotys ($568 million) in damages, citing allegations of anti-competitive practices, Allegro said in a statement. The unit, Ceneo, is demanding compensation for losses it says it has suffered due to Google's practices of preferring...

GDANSK, Dec 23 (Reuters) - A subsidiary of Polish e-commerce platform Allegro on Monday filed a lawsuit against Google-owner Alphabet, Google Ireland, and Google LLC, seeking 2.33 billion zlotys ($568 million) in damages, citing allegations of anti-competitive practices, Allegro said in a statement. The unit, Ceneo, is demanding compensation for losses it says it has suffered due to Google's practices...